164 related articles for article (PubMed ID: 12733655)
1. Targeting cells that overexpress the epidermal growth factor receptor with polyethylene glycolated BPD verteporfin photosensitizer immunoconjugates.
Savellano MD; Hasan T
Photochem Photobiol; 2003 Apr; 77(4):431-9. PubMed ID: 12733655
[TBL] [Abstract][Full Text] [Related]
2. Photochemical targeting of epidermal growth factor receptor: a mechanistic study.
Savellano MD; Hasan T
Clin Cancer Res; 2005 Feb; 11(4):1658-68. PubMed ID: 15746071
[TBL] [Abstract][Full Text] [Related]
3. Multiepitope HER2 targeting enhances photoimmunotherapy of HER2-overexpressing cancer cells with pyropheophorbide-a immunoconjugates.
Savellano MD; Pogue BW; Hoopes PJ; Vitetta ES; Paulsen KD
Cancer Res; 2005 Jul; 65(14):6371-9. PubMed ID: 16024640
[TBL] [Abstract][Full Text] [Related]
4. Targeting doxorubicin to epidermal growth factor receptors by site-specific conjugation of C225 to poly(L-glutamic acid) through a polyethylene glycol spacer.
Vega J; Ke S; Fan Z; Wallace S; Charsangavej C; Li C
Pharm Res; 2003 May; 20(5):826-32. PubMed ID: 12751641
[TBL] [Abstract][Full Text] [Related]
5. Breaking the selectivity-uptake trade-off of photoimmunoconjugates with nanoliposomal irinotecan for synergistic multi-tier cancer targeting.
Liang BJ; Pigula M; Baglo Y; Najafali D; Hasan T; Huang HC
J Nanobiotechnology; 2020 Jan; 18(1):1. PubMed ID: 31898555
[TBL] [Abstract][Full Text] [Related]
6. Epidermal growth factor receptor-targeted photosensitizer selectively inhibits EGFR signaling and induces targeted phototoxicity in ovarian cancer cells.
Abu-Yousif AO; Moor AC; Zheng X; Savellano MD; Yu W; Selbo PK; Hasan T
Cancer Lett; 2012 Aug; 321(2):120-7. PubMed ID: 22266098
[TBL] [Abstract][Full Text] [Related]
7. Photoactive immunoconjugates for targeted photodynamic therapy of cancer.
Fernandes SRG; Mohajershojai T; Lundsten S; Sarmento B; Tomé JPC; Nestor M; Jha P
J Photochem Photobiol B; 2023 Jun; 243():112716. PubMed ID: 37126865
[TBL] [Abstract][Full Text] [Related]
8. A Rational design of multi-functional nanoplatform: Fluorescent-based "off-on" theranostic gold nanoparticles modified with D-α-Tocopherol succinate.
Demiral A; Verimli N; Goralı Sİ; Yılmaz H; Çulha M; Erdem SS
J Photochem Photobiol B; 2021 Sep; 222():112261. PubMed ID: 34330081
[TBL] [Abstract][Full Text] [Related]
9. Photodynamic tumor eradication with a novel targetable photosensitizer: strong vascular effects and dependence on treatment repetition versus potentiation.
Savellano MD; Owusu-Brackett N; Son J; Ganga T; Leung NL; Savellano DH
Photochem Photobiol; 2013; 89(3):687-97. PubMed ID: 23145766
[TBL] [Abstract][Full Text] [Related]
10. Conjugation with (111)In-DTPA-poly(ethylene glycol) improves imaging of anti-EGF receptor antibody C225.
Wen X; Wu QP; Ke S; Ellis L; Charnsangavej C; Delpassand AS; Wallace S; Li C
J Nucl Med; 2001 Oct; 42(10):1530-7. PubMed ID: 11585869
[TBL] [Abstract][Full Text] [Related]
11. Antibody-targeted photodynamic therapy.
Mayo GL; Melendez RF; Kumar N; McKinnon SJ; Glickman RD
Am J Ophthalmol; 2003 Dec; 136(6):1151-2. PubMed ID: 14644227
[TBL] [Abstract][Full Text] [Related]
12. Photoimmunotherapy Using Cationic and Anionic Photosensitizer-Antibody Conjugates against HIV Env-Expressing Cells.
Sadraeian M; Bahou C; da Cruz EF; Janini LMR; Sobhie Diaz R; Boyle RW; Chudasama V; Eduardo Gontijo Guimarães F
Int J Mol Sci; 2020 Dec; 21(23):. PubMed ID: 33271741
[TBL] [Abstract][Full Text] [Related]
13. Panitumumab Modified with Metal-Chelating Polymers (MCP) Complexed to
Aghevlian S; Lu Y; Winnik MA; Hedley DW; Reilly RM
Mol Pharm; 2018 Mar; 15(3):1150-1159. PubMed ID: 29314858
[TBL] [Abstract][Full Text] [Related]
14. Assembly of High-Potency Photosensitizer-Antibody Conjugates through Application of Dendron Multiplier Technology.
Bryden F; Maruani A; Rodrigues JMM; Cheng MHY; Savoie H; Beeby A; Chudasama V; Boyle RW
Bioconjug Chem; 2018 Jan; 29(1):176-181. PubMed ID: 29216717
[TBL] [Abstract][Full Text] [Related]
15. Photodynamic therapy using an anti-EGF receptor antibody complexed with verteporfin nanoparticles: a proof of concept study.
Kameyama N; Matsuda S; Itano O; Ito A; Konno T; Arai T; Ishihara K; Ueda M; Kitagawa Y
Cancer Biother Radiopharm; 2011 Dec; 26(6):697-704. PubMed ID: 21861705
[TBL] [Abstract][Full Text] [Related]
16. Defining the therapeutic window of vertebral photodynamic therapy in a murine pre-clinical model of breast cancer metastasis using the photosensitizer BPD-MA (Verteporfin).
Akens MK; Hardisty MR; Wilson BC; Schwock J; Whyne CM; Burch S; Yee AJ
Breast Cancer Res Treat; 2010 Jan; 119(2):325-33. PubMed ID: 19263216
[TBL] [Abstract][Full Text] [Related]
17. Sensitivity of activated murine peritoneal macrophages to photodynamic killing with benzoporphyrin derivative.
Hunt DW; Jiang HJ; Levy JG; Chan AH
Photochem Photobiol; 1995 Apr; 61(4):417-21. PubMed ID: 7740088
[TBL] [Abstract][Full Text] [Related]
18. Targeting of a hydrophilic photosensitizer by use of internalizing monoclonal antibodies: A new possibility for use in photodynamic therapy.
Vrouenraets MB; Visser GW; Loup C; Meunier B; Stigter M; Oppelaar H; Stewart FA; Snow GB; van Dongen GA
Int J Cancer; 2000 Oct; 88(1):108-14. PubMed ID: 10962447
[TBL] [Abstract][Full Text] [Related]
19. Effect of charge on the interaction of site-specific photoimmunoconjugates with human ovarian cancer cells.
Hamblin MR; Miller JL; Hasan T
Cancer Res; 1996 Nov; 56(22):5205-10. PubMed ID: 8912858
[TBL] [Abstract][Full Text] [Related]
20. Verteporfin mediated sequence dependent combination therapy against ovarian cancer cell line.
Erdem SS; Obeidin VA; Yigitbasi T; Tumer SS; Yigit P
J Photochem Photobiol B; 2018 Jun; 183():266-274. PubMed ID: 29747146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
